단층 촬영용 MRI 시스템 시장 예측(2026-2032년)

The MRI System for Tomography Market is projected to grow by USD 10.13 billion at a CAGR of 6.05% by 2032.

MRI Systems for Tomography: Executive Overview

MRI systems for tomography use magnetic fields, radiofrequency energy, and computational reconstruction to produce detailed cross-sectional images without ionizing radiation. Their clinical value is strongest in neurological, musculoskeletal, cardiovascular, abdominal, and oncological assessment, where soft-tissue contrast and multiplanar imaging support diagnosis and treatment planning. Adoption is shaped by clinical demand, equipment accessibility, workflow requirements, safety standards, reimbursement conditions, and the availability of trained personnel.

Workflow, Safety, and Access Are Reshaping MRI Deployment

The landscape is shifting toward systems that improve examination throughput, patient comfort, motion management, and energy efficiency while maintaining diagnostic quality. Shorter protocols, wider-bore designs, automated positioning, advanced coils, and improved acoustic control address operational and patient-experience challenges. At the same time, healthcare providers are emphasizing lifecycle service, uptime, cybersecurity, interoperability, siting requirements, and total operating cost rather than evaluating scanners solely on image quality.

Artificial Intelligence Is Accelerating Image Reconstruction and Clinical Workflows

Artificial intelligence is contributing to accelerated image reconstruction, denoising, motion correction, protocol selection, quality assurance, segmentation, and structured interpretation support. These applications can reduce repeat examinations and help technologists manage complex workflows, but their clinical value depends on representative validation, transparent performance monitoring, integration with radiology information systems, and appropriate human oversight. Data governance, bias control, cybersecurity, and regulatory compliance remain essential as AI becomes more embedded in MRI operations.

Regional Insights: Uneven Access Meets Broad Clinical Demand

North America is characterized by advanced imaging infrastructure, strong specialty care networks, and emphasis on workflow productivity and replacement planning. Europe combines mature hospital systems with rigorous safety, procurement, sustainability, and data-governance requirements. Asia-Pacific includes highly developed imaging markets alongside rapidly expanding healthcare capacity, creating varied demand for premium, mid-range, and access-oriented systems. Latin America is influenced by urban concentration of specialist services, import and maintenance conditions, and differences in reimbursement. The Middle East is investing in modern hospital infrastructure and centralized specialty care, while the African market remains shaped by equipment affordability, reliable power, service coverage, and workforce availability.

Group Insights: Policy Alignment and Health-System Structure Matter

ASEAN markets reflect diverse levels of healthcare development, with regional cooperation supporting capacity building while local procurement and reimbursement conditions remain decisive. BRICS countries show varied approaches to domestic manufacturing, public-sector investment, clinical training, and technology access. European Union members operate within shared regulatory and data-protection frameworks while retaining national purchasing and reimbursement practices. G7 systems generally prioritize advanced clinical capability, productivity, safety, and evidence-based procurement. GCC countries are strengthening centralized, high-acuity healthcare networks, and NATO members must also consider resilience, interoperability, cybersecurity, and continuity of medical services.

Country Insights: Diverse Priorities Across Major MRI Markets

Australia emphasizes geographically distributed access, hospital efficiency, and specialist workforce capacity. Brazil and Mexico face regional disparities in advanced imaging availability and place importance on serviceability and public-private coordination. Canada and the United States prioritize replacement cycles, clinical productivity, outpatient access, and integration with complex care networks. China and India are expanding diagnostic capacity while balancing affordability, domestic capability, and workforce development. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom operate mature imaging ecosystems where quality, safety, sustainability, reimbursement, and efficient utilization influence procurement. Russia's MRI access and modernization priorities are affected by infrastructure, supply continuity, and regional healthcare disparities.

Actions for Leaders: Build Resilient, Workflow-Centered MRI Strategies

Industry leaders should segment offerings by clinical use, facility capability, patient population, and service environment rather than applying a single global configuration. Priorities should include dependable installation and maintenance networks, workforce training, interoperable software, cybersecurity-by-design, and transparent validation of AI-enabled functions. Providers can improve returns on installed systems by standardizing protocols, monitoring utilization and repeat-scan rates, coordinating referral pathways, and selecting upgrades that address measurable workflow constraints. Procurement decisions should assess lifecycle performance, energy use, accessibility, regulatory obligations, and continuity plans alongside technical specifications.

Research Methodology: Evidence-Based Assessment of MRI System Dynamics

This executive summary applies a structured secondary-research approach focused on verified information from health authorities, regulatory bodies, clinical and technical literature, professional societies, public procurement materials, and established healthcare policy sources. Findings are organized by technology, workflow, clinical application, geography, and health-system context. Regional, group, and country comparisons consider infrastructure, access, workforce, regulation, reimbursement, service requirements, and adoption conditions. Interpretations are qualitative and deliberately exclude market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Clinical Utility Depends on Integration and Execution

MRI systems for tomography remain central to nonionizing diagnostic imaging, but their impact depends on more than scanner capability. Sustainable progress requires coordinated attention to patient-centered design, efficient protocols, skilled personnel, reliable infrastructure, responsible AI, interoperability, and equitable access. Organizations that connect technology decisions with measurable clinical and operational objectives will be better positioned to improve diagnostic pathways across diverse regional, group, and country settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. MRI System for Tomography Market, by Component

• 7.1. Introduction
• 7.2. Scanner
  • 7.2.1. Closed Bore
  • 7.2.2. Open Bore
  • 7.2.3. Wide Bore
• 7.3. Service
  • 7.3.1. Aftermarket
  • 7.3.2. Installed Base
• 7.4. Software

8. MRI System for Tomography Market, by Field Strength

• 8.1. Introduction
• 8.2. Low Field
• 8.3. One Point Five Tesla
• 8.4. Three Tesla
• 8.5. Ultra High Field

9. MRI System for Tomography Market, by End User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Diagnostic Centers
• 9.4. Hospitals

10. MRI System for Tomography Market, by Application

• 10.1. Introduction
• 10.2. Cardiac
  • 10.2.1. Heart
  • 10.2.2. Vascular
• 10.3. Musculoskeletal
• 10.4. Neurology
  • 10.4.1. Brain
  • 10.4.2. Spinal Cord
• 10.5. Oncology
  • 10.5.1. Breast
  • 10.5.2. Prostate

11. MRI System for Tomography Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. MRI System for Tomography Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. MRI System for Tomography Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Allied Healthcare Products Inc
• 15.2. Analogic Corporation
• 15.3. Aspect Imaging Ltd
• 15.4. Aurora Imaging Technology Inc
• 15.5. Bruker Corporation
• 15.6. Canon Inc
• 15.7. Carestream Health Inc
• 15.8. Esaote S.p.A
• 15.9. Fonar Corporation
• 15.10. Fujifilm Holdings Corporation
• 15.11. General Electric Company
• 15.12. Hitachi Ltd
• 15.13. Hologic Inc
• 15.14. Hyperfine Inc
• 15.15. Konica Minolta Inc
• 15.16. Koninklijke Philips N.V
• 15.17. Mindray Bio-Medical Electronics Co Ltd
• 15.18. Neusoft Medical Systems Co Ltd
• 15.19. Nihon Kohden Corporation
• 15.20. Samsung Medison Co Ltd
• 15.21. Shimadzu Corporation
• 15.22. Siemens Healthineers AG
• 15.23. Synaptive Medical Inc
• 15.24. Time Medical Systems Co Ltd
• 15.25. United Imaging Healthcare Co Ltd

16. Key Experts